Intracrinology of breast microenvironment: hormonal status in nipple aspirate fluid and its relationship to breast cancer

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
   PubMed Web of Science ®Google Scholar
• Fabian CJ, Kimler BF, Mayo MS, Khan SA. Breast-tissue sampling for risk assessment and prevention. Endocr. Relat. Cancer12(2), 185–213 (2005).
   PubMed Web of Science ®Google Scholar
• Gralow J, Ozols RF, Bajorin DF et al. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening – a report from the American Society of Clinical Oncology. J. Clin. Oncol.26(2), 313–325 (2008).
   PubMedGoogle Scholar
• Sauter ER. Analysis of nipple aspirate fluid for diagnosis of breast cancer: an alternative to invasive biopsy. Expert Rev. Mol. Diagn.5(6), 873–881 (2005).
   PubMed Web of Science ®Google Scholar
• Mannello F, Tonti GA, Canestrari F. Nutrients and nipple aspirate fluid composition: the breast microenvironment regulates protein expression and cancer aetiology. Genes Nutr.3, 77–85 (2008).
   PubMed Web of Science ®Google Scholar
• Sauter ER, Ross E, Daly M et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br. J. Cancer76(4), 494–501 (1997).
   PubMed Web of Science ®Google Scholar
• Keynes G. Chronic mastitis. Br. J. Surgery11, 89–121 (1923).
   Google Scholar
• Petrakis NL. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid. Breast Cancer Res. Treat.8(1), 7–19 (1986).
   PubMed Web of Science ®Google Scholar
• Petrakis NL. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol. Biomarkers Prev.2(1), 3–10 (1993).
   PubMed Web of Science ®Google Scholar
• Dua RS, Isacke CM, Gui GP. The intraductal approach to breast cancer biomarker discovery. J. Clin. Oncol.24(7), 1209–1216 (2006).
   PubMed Web of Science ®Google Scholar
• Adair FE, Bagg HJ. Breast stasis as the cause of mammary cancer. Int. Clin.4, 19–26 (1925).
   Google Scholar
• Sartorius OW. Breast fluid cells help in early cancer detection. JAMA224, 823–827 (1973).
   Google Scholar
• Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J. Natl Cancer Inst.54(4), 829–834 (1975).
   PubMed Web of Science ®Google Scholar
• Sartorius OW. The biochemistry of breast cyst fluids and duct secretions. Breast Cancer Res. Treat.35(3), 255–266 (1995).
   PubMedGoogle Scholar
• Sauter ER, Ehya H, Babb J et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br. J. Cancer81(7), 1222–1227 (1999).
   PubMed Web of Science ®Google Scholar
• Mannello F. Analysis of the intraductal microenvironment for the early diagnosis of breast cancer: identification of biomarkers in nipple-aspirate fluids. Expert Opin. Med. Diagn.2(11), 1221–1231 (2008).
   PubMedGoogle Scholar
• Mannello F, Tonti GA, Papa S. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies. Breast Cancer Res. Treat.97(2), 115–129 (2006).
   PubMed Web of Science ®Google Scholar
• Malatesta M, Mannello F, Bianchi G, Sebastiani M, Gazzanelli G. Biochemical and ultrastructural features of human milk and nipple aspirate fluids. J. Clin. Lab. Anal.14(6), 330–335 (2000).
   PubMed Web of Science ®Google Scholar
• Petrakis NL, Barnes S, King EB et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol. Biomarkers Prev.5(10), 785–794 (1996).
   PubMed Web of Science ®Google Scholar
• Sauter ER, Winn JN, Dale PS, Wagner-Mann C. Nipple aspirate fluid color is associated with breast cancer. Cancer Detect. Prev.30(4), 322–328 (2006).
   PubMedGoogle Scholar
• Kato I, Ren J, Heilbrun LK, Djuric Z. Intra- and inter-individual variability in measurements of biomarkers for oxidative damage in vivo: NUTRITION and Breast Health Study. Biomarkers11(2), 143–152 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang L, Shao ZM, Beatty P et al. The use of oxytocin in nipple fluid aspiration. Breast J.9(4), 266–268 (2003).
   PubMedGoogle Scholar
• Suijkerbuijk KP, van der WE, van Diest PJ. Oxytocin: bringing magic into nipple aspiration. Ann. Oncol.18(10), 1743–1744 (2007).
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk KP, van der WE, Vooijs M, van Diest PJ. Molecular analysis of nipple fluid for breast cancer screening. Pathobiology75(2), 149–152 (2008).
   PubMed Web of Science ®Google Scholar
• Mannello F, Medda V, Tonti GA. Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients. Expert Rev. Proteomics6(1), 43–60 (2009).
   PubMed Web of Science ®Google Scholar
• Sauter ER, Wagner-Mann C, Ehya H, Klein-Szanto A. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect. Prev.31(1), 50–58 (2007).
   PubMedGoogle Scholar
• Sasano H, Suzuki T, Nakata T, Moriya T. New development in intracrinology of breast carcinoma. Breast Cancer13(2), 129–136 (2006).
   PubMedGoogle Scholar
• Suzuki T, Miki Y, Moriya T et al.In situ production of sex steroids in human breast carcinoma. Med. Mol. Morphol.40(3), 121–127 (2007).
   PubMedGoogle Scholar
• Sasano H, Suzuki T, Harada N. From endocrinology to intracrinology. Endocr. Pathol.9(1), 9–20 (1998).
   PubMedGoogle Scholar
• Li J, Zhao J, Yu X et al. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin. Cancer Res.11(23), 8312–8320 (2005).
   PubMed Web of Science ®Google Scholar
• Spicer DV, Pike MC. The prevention of breast cancer through reduced ovarian steroid exposure. Acta Oncol.31(2), 167–174 (1992).
   PubMed Web of Science ®Google Scholar
• Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev.15(1), 17–35 (1993).
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Willett WC, Colditz GA et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet351(9113), 1393–1396 (1998).
   PubMed Web of Science ®Google Scholar
• Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl Cancer Inst.87(3), 190–197 (1995).
   PubMed Web of Science ®Google Scholar
• Sturgeon SR, Potischman N, Malone KE et al. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case–control study (USA). Cancer Causes Control15(1), 45–53 (2004).
   PubMed Web of Science ®Google Scholar
• Suzuki T, Miki Y, Ohuchi N, Sasano H. Intratumoral estrogen production in breast carcinoma: significance of aromatase. Breast Cancer15(4), 270–277 (2008).
   PubMed Web of Science ®Google Scholar
• Chatterton RT Jr, Geiger AS, Gann PH, Khan SA. Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J. Steroid Biochem. Mol. Biol.86(2), 159–166 (2003).
   PubMed Web of Science ®Google Scholar
• Wynder EL, Hill P. Prolactin, oestrogen, and lipids in breast fluid. Lancet2(8043), 840–842 (1977).
   PubMed Web of Science ®Google Scholar
• Miller WR, Hawkins RA, Creel RJ, Forrest AP. Oestrogen in breast fluid. Lancet2(8049), 1179 (1977).
   PubMedGoogle Scholar
• Wynder EL, Hill P, Laakso K, Littner R, Kettunen K. Breast secretion in Finnish women: a metabolic epidemiologic study. Cancer47(6), 1444–1450 (1981).
   PubMedGoogle Scholar
• Mannello F, Tonti GA, Medda V, Pederzoli A, Sauter ER. Increased shedding of soluble fragments of p-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci.99(11), 2160–2169 (2008).
   PubMedGoogle Scholar
• Mannello F, Tonti GA, Qin W, Zhu W, Sauter ER. Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development?. Breast Cancer Res. Treat.102(1), 125–127 (2007).
   PubMed Web of Science ®Google Scholar
• Petrakis NL, Wrensch MR, Ernster VL et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int. J. Cancer40(5), 587–591 (1987).
   PubMed Web of Science ®Google Scholar
• Ernster VL, Wrensch MR, Petrakis NL et al. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J. Natl Cancer Inst.79(5), 949–960 (1987).
   PubMed Web of Science ®Google Scholar
• King EB, Chew KL, Petrakis NL, Ernster VL. Nipple aspirate cytology for the study of breast cancer precursors. J. Natl Cancer Inst.71(6), 1115–1121 (1983).
   PubMed Web of Science ®Google Scholar
• Tice JA, Miike R, Adduci K, Petrakis NL, King E, Wrensch MR. Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population. Cancer Epidemiol. Biomarkers Prev.14(2), 324–328 (2005).
   PubMed Web of Science ®Google Scholar
• Wrensch MR, Petrakis NL, Miike R et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J. Natl Cancer Inst.93(23), 1791–1798 (2001).
   PubMed Web of Science ®Google Scholar
• Rose DP. Hormones in breast fluid. Breast Cancer Res. Treat.8(1), 25–28 (1986).
   PubMed Web of Science ®Google Scholar
• Hill P, Garbaczewski L, Wynder EL. Testosterone in breast fluid. Lancet1(8327), 761 (1983).
   PubMedGoogle Scholar
• Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH. Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol. Biomarkers Prev.13(6), 928–935 (2004).
   PubMed Web of Science ®Google Scholar
• Rose DP, Berke B, Cohen LA, Lahti H. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease. Cancer60(11), 2761–2765 (1987).
   PubMed Web of Science ®Google Scholar
• Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol. Biomarkers Prev.15(1), 39–44 (2006).
   PubMed Web of Science ®Google Scholar
• Chatterton RT Jr, Geiger AS, Mateo ET, Helenowski IB, Gann PH. Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement. J. Clin. Endocrinol. Metab.90(3), 1686–1691 (2005).
   PubMed Web of Science ®Google Scholar
• Khan SA, Bhandare D, Chatterton RT Jr. The local hormonal environment and related biomarkers in the normal breast. Endocr. Relat. Cancer12(3), 497–510 (2005).
   PubMed Web of Science ®Google Scholar
• Sasano H, Nagasaki S, Miki Y, Suzuki T. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase. Ann. NY Acad. Sci.1155, 76–79 (2009).
   PubMed Web of Science ®Google Scholar
• Miller WR, Humeniuk V, Kelly RW. Dehydroepiandrosterone sulphate in breast secretions. J. Steroid Biochem.13(2), 145–151 (1980).
   PubMedGoogle Scholar
• Miller WR, Humeniuk V, Forrest AP. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast Cancer Res. Treat.1(3), 267–272 (1981).
   PubMedGoogle Scholar
• Boccuzzi G, Brignardello E, Massobrio M, Bonino L. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. Eur. J. Cancer Clin. Oncol.23(8), 1099–1102 (1987).
   PubMedGoogle Scholar
• Kuhn-Velten WN. Intracrinology and the local enzymatic control of hormone distribution and metabolism: dehydroepiandrosterone does not just act as a prohormone for androgens and estrogens. Eur. J. Clin. Invest30(Suppl. 3), 34–38 (2000).
   PubMedGoogle Scholar
• Perel E, Killinger DW. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. J. Steroid Biochem.19(2), 1135–1139 (1983).
   PubMedGoogle Scholar
• Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ. Health Perspect.110(3), 241–246 (2002).
   PubMed Web of Science ®Google Scholar
• Rose DP, Boyar AP, Kettunen K. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women. Nutr. Cancer11(3), 179–187 (1988).
   PubMed Web of Science ®Google Scholar
• Rose DP. Hormones and growth factors in nipple aspirates from normal women and benign breast disease patients. Cancer Detect. Prev.16(1), 43–51 (1992).
   PubMedGoogle Scholar
• Harding C, Osundeko O, Tetlow L, Faragher EB, Howell A, Bundred NJ. Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity. Br. J. Cancer82(2), 354–360 (2000).
   PubMedGoogle Scholar
• Eskelinen M, Kataja V, Hamalainen E, Kosma VM. Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study. Anticancer Res.19(4C), 3463–3467 (1999).
   PubMedGoogle Scholar
• Mitchell G, Sibley PE, Wilson AP, Sauter E, A’Hern R, Eeles RA. Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen. Tumour Biol.23(5), 287–297 (2002).
   PubMedGoogle Scholar
• Sauter ER, Babb J, Daly M et al. Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol. Biomarkers Prev.7(4), 315–320 (1998).
   PubMedGoogle Scholar
• Sauter ER, Klein G, Wagner-Mann C, Diamandis EP. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect. Prev.28(1), 27–31 (2004).
   PubMedGoogle Scholar
• Mannello F, Malatesta M, Sebastiani M, Battistelli S, Gazzanelli G. Molecular forms and ultrastructural localization of prostate-specific antigen in nipple aspirate fluids. Clin. Chem.45(12), 2263–2266 (1999).
   PubMed Web of Science ®Google Scholar
• Sauter ER, Lininger J, Magklara A, Hewett JE, Diamandis EP. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk. Int. J. Cancer108(4), 588–591 (2004).
   PubMedGoogle Scholar
• Zhao Y, Verselis SJ, Klar N et al. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J. Clin. Oncol.19(5), 1462–1467 (2001).
   PubMed Web of Science ®Google Scholar
• Mannello F, Gazzanelli G. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?. Breast Cancer Res.3(4), 238–243 (2001).
   PubMed Web of Science ®Google Scholar
• Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: a review. Biochim. Biophys. Acta1654(2), 123–143 (2004).
   PubMed Web of Science ®Google Scholar
• Jansson A. 17β-hydroxysteroid dehydrogenase enzymes and breast cancer. J. Steroid Biochem. Mol. Biol.114(1–2), 64–67 (2009).
   PubMed Web of Science ®Google Scholar
• King BL, Love SM. The intraductal approach to the breast: raison d’etre. Breast Cancer Res.8(2), 206 (2006).
   PubMedGoogle Scholar
• Rochman S, Mills D, Kim J, Kuerer H, Love S. State of the science and the intraductal approach for breast cancer: proceedings summary of the Sixth International Symposium on the Intraductal Approach to Breast Cancer, Santa Monica, California, 19–21 February 2009. BMC Proc.3(Suppl. 5), I1 (2009).
   Google Scholar
• Sauter ER, Garofalo C, Hewett J, Hewett JE, Morelli C, Surmacz E. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Horm. Metab. Res.36(5), 336–340 (2004).
   PubMed Web of Science ®Google Scholar
• Connolly JM, Rose DP. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci.42(18), 1751–1756 (1988).
   PubMed Web of Science ®Google Scholar
• Black MH, Magklara A, Obiezu C et al. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br. J. Cancer82(2), 361–367 (2000).
   PubMed Web of Science ®Google Scholar